Back

Long-term clinical course and prognostic factors of heart failure with reduced ejection fraction (HFrEF) patients underwent primary prophylactic implantable cardioverter defibrillator (ICD)

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Prognosis and outcomes of various disease states Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Masafumi Sugawara

Chiba University Hospital, Chiba (Japan)

4 More presentations in this session

Presentation thumbnail
Cryptogenic stroke and extrasystolic arrythmia: is there any correlation?
Assistant Professor O. Germanova (Bishkek, KG)
Abstract Slides
Presentation thumbnail
Impact of atrial fibrillation on outcome of percutaneous mitral valve repair (PMVR) procedure
Doctor Y. Mohrez (Aschaffenburg, DE)
Abstract Slides
Presentation thumbnail
Factors associated with the presence of thrombus in the left atrial appendage and usefulness of the D-Dimer to rule out its presence
Doctor P. Irigaray (Lleida, ES)
Abstract Slides
Presentation thumbnail
Predictive value of late gadolinium enhancement MRI in patients with persistent atrial fibrillation. Multicentric validation of a standardised method
Doctor T. Althoff (Berlin, DE)
Abstract Slides

Access the full session

Session thumbnail
Prognosis and outcomes of various disease states

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources